Global In Vitro Fertilization (IVF) Market Size, Share & Forecast 2025-2033

IVF Market Size & Forecast 2025-2033

The global In Vitro Fertilization Market was valued at US$ 26.43 billion in 2024 and is expected to grow to US$ 49.12 billion by 2033, registering a CAGR of 7.13% from 2025 to 2033. The growth is attributed to the rise in infertility rates, innovation in assisted reproductive technologies, and increased awareness about fertility treatments, bringing hope to couples across the globe who are seeking solutions for parenthood.

The report In Vitro Fertilization Market & Forecast covers by Procedure Type (Fresh non-donor, Frozen non-donor, Fresh Donor, Frozen Donor), Instrument (Disposable Devices, Culture Media, Equipment), Surgery (Embryo Culture, Cryopreservation, Sperm Processing, Ovum Processing, End Users (Fertility Clinics, Hospitals & Other Setting), Country and Company Analysis 2025-2033.

In Vitro Fertilization Market Overview

In vitro fertilization (IVF) is a medical technique for when the body, in itself, cannot conceive or reproduce. The procedure consists of fertilizing an egg with sperm outside the body, generally from a laboratory dish. Once the fertilization is complete, the resulting embryo is placed into the uterus to attempt to form a pregnancy. IVF is the most commonly used application to alleviate a range of fertility issues, from fallopian tubes that are blocked, low concentration of sperm, ovulation disorders, or unexplained infertility.

IVF also represents a very viable procedure for prospective persons or couples who wish to preserve fertility via the freezing of eggs or embryos, or same-sex couples and single parents who intend to conceive via donor sperm, donor eggs, or surrogacy. It is now used in genetic screening, where it allows the detection of diseases prior to implantation. IVF has been that versatile and successful that it has revolutionized the practice in reproductive medicine. With ongoing technological advancements and increased accessibility, IVF has helped millions of people around the world bring their dreams of parenthood to fruition.

Growth Drivers in the IVF Industry

Escalation of Worldwide Infertility Rates

Growth in the rates of infertility is motivated more by lifestyle changes, the payments of pregnancies at more mature ages, obesity, and also environmental issues. Infertility now affects millions worldwide, and couples are turning to assisted reproductive technologies like IVF for solutions. In addition, increased awareness of fertility options and improving diagnostic capabilities have further boosted the adoption of IVF services worldwide. April 2023, A new WHO report reveals that approximately 17.5% of adults—about 1 in 6 globally—experience infertility, highlighting the urgent need for increased access to affordable, high-quality fertility care.

Technological Advancements in IVF

The constant advancement in IVF technology, including time-lapse embryo imaging, preimplantation genetic testing (PGT), and cryopreservation techniques, has improved success rates and patient outcomes. Minimally invasive procedures and AI-driven embryo selection have also made IVF more accessible and effective. All these advancements along with increased funding for research are major growth drivers in the IVF market. In 2023, Hamilton Thorne Nederland BV acquired Gynetics MP NV and Gynetics S, BV, thereby expanding its operations in the European mature ART market on more profitable dealings.

Rising Medical Tourism for IVF

Spurred medical tourism due to cost-effective IVF treatment availability in countries like India, Thailand, and Spain. Affluent regions' couples made medical tourist movements to these destination countries for cost-effective yet high-quality fertility care. Ease of regulations, richly experienced medical professionals, and international centers contribute vastly to the demand for IVF. India currently performs 2-2.5 lakh IVF cycles annually, with projections citing a rise by 2030 to 5-6 lakh cycles per year.

Barriers in the In Vitro Fertilization Market

Cost of IVF Procedures is Very High

High cost of treatments is the most important deterrent to the growth of the IVF market. In most parts of the world, multiple cycles and medication expenses make IVF unaffordable for a major segment of the population. In some areas, insurance coverage is increasing, but the problem is still very challenging in low-income and developing countries.

Ethical and Legal Issues

Ethical issues, including embryo disposal, genetic modification, and surrogacy regulations, create a challenge in the IVF market. Various countries have different legal frameworks and cultural perceptions about fertility treatments, which can act as a hindrance to market growth. Moreover, religious beliefs and societal stigma about assisted reproductive technologies often discourage people from seeking IVF solutions.

In Vitro Fertilization Fresh Donor Market

The fresh donor market is the use of fresh eggs from donors for IVF procedures. This segment is growing due to high success rates associated with fresh egg usage. Fresh donor cycles are preferred for their higher embryo quality, making them a popular choice among intended parents. With increasing demand for donor programs and better donor-egg matching systems, this market continues to expand globally.

In Vitro Fertilization Disposable Devices Market

Disposable devices that are used in IVF include pipettes, culture dishes, and needles, which ensure sterility and prevent contamination during procedures. The increased adoption of single-use devices enhances the safety and efficiency of IVF treatments. The disposable devices play a crucial role in maintaining quality standards in fertility clinics. With the increasing volume of IVF procedures, the demand for disposable devices is constantly increasing.

In Vitro Fertilization Embryo Culture Media Market

Embryo culture media are very crucial in supporting the development of embryos during IVF. Advances in media formulations have improved embryo viability, which enhances overall success rates. As there is a growing interest in optimizing embryo culture conditions, the market for specialized media, such as sequential and single-step culture systems, is growing. The increase in fertility clinic establishments further fuels the demand for quality embryo culture media.

In Vitro Fertilization Fertility Clinics Market

Fertility clinics form the backbone of the IVF market, providing high-end reproductive care and tailored treatment options. Fertility clinics provide diagnostics, hormone therapies, and IVF procedures. A surge in cases of infertility and an increased awareness about reproductive health has resulted in fertility clinic establishments increasing worldwide, fueling the market.

In Vitro Fertilization Market Overview by Regions

United States In Vitro Fertilization Market

The United States is one of the largest IVF markets, driven by advanced healthcare infrastructure and high awareness of fertility treatments. Increasing infertility rates, insurance coverage expansions, and continuous innovations in reproductive technologies have propelled growth. The presence of leading fertility clinics and the availability of genetic screening further strengthen the U.S. IVF market. September 2023, Merck is launching a comprehensive Fertility Benefit program that pays for fertility treatment for employees. The company currently offers the same benefits to employees in the U.S., Canada, and Japan.

United Kingdom In Vitro Fertilization Market

The IVF market is growing in the UK as well, driven by government support and increasing demand for fertility treatments. The National Health Service (NHS) provides partial or full coverage for IVF in certain cases, making treatments accessible. Technological advancements, coupled with an increasing number of fertility clinics, contribute to market growth in the region. In Jan 2024, People seeking fertility treatments like IVF can now use an online tool to compare NHS funding in their area with the rest of the UK. This is a dashboard launched by the Human Fertility and Embryology Authority in a world first. Access is provided both to users and researchers, having data from all 665,690 patients as far back as 1991.

India In-Vitro Fertilization Market

India is one of the most affordable destination for IVF treatments. Currently, this facility attracts global medical tourists. With the increase in infertility cases and improvement in health care infrastructure along with increasing awareness about assisted reproductive technologies, this market is accelerating. Other contributing factors are advancing IVF technology and growing fertility services among the urban population. February 2024, The Telangana state government opened the first high-end IVF facility at Gandhi Hospital to assist the infertile couples.

Saudi Arabia In Vitro Fertilization Market

Saudi Arabia's IVF market is growing because of the increasing rate of infertility and better awareness about the reproductive treatments. The government has invested in the healthcare infrastructure under Vision 2030, which has improved the availability of advanced IVF services. Cultural acceptance of assisted reproduction and the increasing number of specialized fertility clinics further propel the growth of the market in the region. September 2024, Burjeel Holdings PLC, a top super-specialty healthcare provider, plans to launch IVF services in Saudi Arabia, enhancing its presence in the specialized healthcare sector.

In Vitro Fertilization Market Segmentation

Procedure Type 

• Fresh non-donor
• Frozen non-donor
• Fresh Donor
• Frozen Donor

Instrument 

• Disposable Devices
• Culture Media
• Equipment

Technique

• Intra-Cytoplasmic Sperm Injection
• Traditional IVF
• Preimplantation Genetic Testing
• Cryopreservation
• Embryo Culture

End Users 

• Fertility Clinics
• Hospitals & Other Setting

Regional Analysis

North America

• United States
• Canada

Europe

• France
• Germany
• Italy
• Spain
• United Kingdom
• Belgium
• Netherlands
• Turkey

Asia Pacific

• China
• Japan
• India
• Australia
• South Korea
• Thailand
• Malaysia
• Indonesia
• New Zealand

Latin America

• Brazil
• Mexico
• Argentina

Middle East & Africa

• South Africa
• Saudi Arabia
• UAE

All the Key players have been covered from 4 Viewpoints:

• Overview
• Key Persons
• Recent Development & Strategies
• Financial Insights

Competitive Landscape

• FUJIFILM Holdings Corporation
• Hamilton Thorne Ltd.
• Vitrolife AB
• Thermo Fisher Scientific, Inc.
• Bayer AG
• Merck & Co., Inc.
• The Cooper Companies, Inc.
• Fortis Healthcare

Report Details: